Surendralal L. Karsanbhai - Jan 1, 2025 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Surendralal L. Karsanbhai
Stock symbol
MRK
Transactions as of
Jan 1, 2025
Transactions value $
$55,000
Form type
4
Date filed
1/3/2025, 12:59 PM
Previous filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 1 Jan 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Phantom Stock Award $55K +553 $99.48 553 Jan 1, 2025 Common Stock 553 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3 The price reported is the closing price of Merck Common Stock on the business day immediately prior to the effective date of the Director's service.